"It's obviously great news for people living with schizophrenia," he said, while noting that the drug has yet to receive approval in Britain. Sameer Jauhar, a senior clinical lecturer in affective disorders and psychosis at King's College in London, said the side effects of current medications ?" including weight gain and sluggishness ?" can deter some people from following through with treatment.